TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Gross margin 2023–2025
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) gross margin by fiscal year — reported gross profit divided by reported revenue.
49.3%FY2025 · since FY2023: 39.0% → 49.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 49.3% | +26.3 pp |
| FY2024 | 23.1% | -15.9 pp |
| FY2023 | 39.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice